Literature DB >> 7624108

Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder.

J T Kuikka1, A Pitkänen, U Lepola, K Partanen, P Vainio, K A Bergström, H J Wieler, K P Kaiser, L Mittelbach, H Koponen.   

Abstract

The neuroanatomical networks involved in the initiation of panic attack and the maintenance of panic disorder are poorly understood. This study aimed to elucidate the possible abnormalities in benzodiazepine receptor uptake in the brain of patients with panic disorder. Seventeen unmedicated patients with panic disorder were investigated using 123I-iomazenil single photon emission tomography (SPET). Seventeen healthy age- and sex-matched volunteers served as controls. The SPET scan was taken 90 min after injection of tracer. Eleven of 17 patients (65%) showed an increased (> 2 S.D. higher than the mean of the controls) right-to-left ratio of benzodiazepine receptor uptake in the prefrontal cortex. Also, the mean right-to-left ratio of benzodiazepine receptor uptake in all 17 patients with panic disorder was higher than in the controls (P < 0.001). Our SPET study demonstrated focally altered benzodiazepine receptor uptake in the prefrontal cortices in patients with panic disorder. Magnetic resonance imaging indicated that the affected region was located in the right middle and inferior frontal gyri. The deterioration in information processing in the right prefrontal cortex may be implicated in the generation of panic disorder.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624108     DOI: 10.1097/00006231-199504000-00159

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  7 in total

Review 1.  Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder.

Authors:  Thomas Dresler; Anne Guhn; Sara V Tupak; Ann-Christine Ehlis; Martin J Herrmann; Andreas J Fallgatter; Jürgen Deckert; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2012-06-13       Impact factor: 3.575

2.  Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1,2,4-oxadiazo-3-yl)- 7-iodo-5, 6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]-benzodiazepine (NNC 13-8241).

Authors:  J T Kuikka; J Hiltunen; C Foged; K A Bergström; C Halldin; K Akerman; J Tiihonen; L Farde
Journal:  Eur J Nucl Med       Date:  1996-07

3.  Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results.

Authors:  Ursula M H Klumpers; Dick J Veltman; Madeleine L Drent; Ronald Boellaard; Emile F I Comans; Gerben Meynen; Adriaan A Lammertsma; Witte J G Hoogendijk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-05       Impact factor: 9.236

4.  In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice.

Authors:  S A Heldt; L Mou; K J Ressler
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

Review 5.  The molecular neuroimaging of anxiety disorders.

Authors:  Peter S Talbot
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 8.081

6.  The alterations of degree centrality in the frontal lobe of patients with panic disorder.

Authors:  Yongbao Liu; Chien-Han Lai
Journal:  Int J Med Sci       Date:  2022-01-01       Impact factor: 3.738

Review 7.  Neuroimaging in anxiety disorders.

Authors:  Kirsten Engel; Borwin Bandelow; Oliver Gruber; Dirk Wedekind
Journal:  J Neural Transm (Vienna)       Date:  2008-06-21       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.